+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Opioids Market Outlook 2026-2034: by Product Type (Morphine, Oxycodone, Hydrocodone, Meperidine, Methadone, Others), Route of Administration, Receptor Binding, Application- Product Image
Opioids Market Outlook 2026-2034: by Product Type (Morphine, Oxycodone, Hydrocodone, Meperidine, Methadone, Others), Route of Administration, Receptor Binding, Application- Product Image
Sale

Opioids Market Outlook 2026-2034: by Product Type (Morphine, Oxycodone, Hydrocodone, Meperidine, Methadone, Others), Route of Administration, Receptor Binding, Application

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6115448
UP TO OFF until Jan 01st 2027
Description Jump to:
The Opioids Market is estimated at US$26.5 billion in 2026 and is projected to grow at a CAGR of 4.6% to reach US$38 billion by 2034.

Market Overview

The Opioids Market covers opioid medicines supplied for authorized clinical uses.

Product authorization, prescribing controls and distribution requirements shape the market; legitimate pharmaceutical sales must be distinguished from illicit supply.

Market Segmentation

By Product Type

  • Morphine
  • Oxycodone
  • Hydrocodone
  • Meperidine
  • Methadone
  • Others

By Route of Administration

  • Oral
  • Parenteral / IV
  • Transdermal
  • Others (Sublingual, Nasal, etc.)

By Receptor Binding

  • Strong Agonist
  • Mild-to-Moderate Agonist
  • Partial Agonist
  • Antagonist

By Application

  • Pain Management
  • Cold & Cough
  • Diarrhea
  • Opioid-Dependence Therapy

Key Companies Analysed

  • Purdue Pharma
  • Mallinckrodt
  • Teva Pharmaceutical Industries
  • Johnson & Johnson
  • Pfizer
  • Sun Pharmaceutical
  • Viatris
  • Hikma Pharmaceuticals
  • Endo International
  • Collegium Pharmaceutical
  • Indivior
  • Mundipharma
  • Zydus Lifesciences
  • Sanofi
  • Sandoz
  • Amneal Pharmaceuticals
  • Bausch Health
  • Cipla
  • Dr. Reddy's Laboratories
  • Eli Lilly

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Opioids Market Overview
2.1. Opioids Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Opioids Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Opioids Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Opioids Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Opioids Market Analysis By Product Type, 2025-2034
5.2.1. Morphine
5.2.2. Oxycodone
5.2.3. Hydrocodone
5.2.4. Meperidine
5.2.5. Methadone
5.2.6. Others
5.3. Opioids Market Analysis By Route of Administration, 2025-2034
5.3.1. Oral
5.3.2. Parenteral / IV
5.3.3. Transdermal
5.3.4. Others (Sublingual, Nasal, etc.)
5.4. Opioids Market Analysis By Receptor Binding, 2025-2034
5.4.1. Strong Agonist
5.4.2. Mild-to-Moderate Agonist
5.4.3. Partial Agonist
5.4.4. Antagonist
5.5. Opioids Market Analysis By Application, 2025-2034
5.5.1. Pain Management
5.5.2. Cold & Cough
5.5.3. Diarrhea
5.5.4. Opioid-Dependence Therapy
6. North America Opioids Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Opioids Market Analysis By Product Type
6.3. North America Opioids Market Analysis By Route of Administration
6.4. North America Opioids Market Analysis By Receptor Binding
6.5. North America Opioids Market Analysis By Application
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Opioids Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Opioids Market Analysis By Product Type
7.3. Europe Opioids Market Analysis By Route of Administration
7.4. Europe Opioids Market Analysis By Receptor Binding
7.5. Europe Opioids Market Analysis By Application
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Opioids Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Opioids Market Analysis By Product Type
8.3. Asia-Pacific Opioids Market Analysis By Route of Administration
8.4. Asia-Pacific Opioids Market Analysis By Receptor Binding
8.5. Asia-Pacific Opioids Market Analysis By Application
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Opioids Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Opioids Market Analysis By Product Type
9.3. Middle East and Africa Opioids Market Analysis By Route of Administration
9.4. Middle East and Africa Opioids Market Analysis By Receptor Binding
9.5. Middle East and Africa Opioids Market Analysis By Application
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Opioids Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Opioids Market Analysis By Product Type
10.3. South and Central America Opioids Market Analysis By Route of Administration
10.4. South and Central America Opioids Market Analysis By Receptor Binding
10.5. South and Central America Opioids Market Analysis By Application
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Opioids Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Purdue Pharma
11.2.2. Mallinckrodt
11.2.3. Teva Pharmaceutical Industries
11.2.4. Johnson & Johnson
11.2.5. Pfizer
11.2.6. Sun Pharmaceutical
11.2.7. Viatris
11.2.8. Hikma Pharmaceuticals
11.2.9. Endo International
11.2.10. Collegium Pharmaceutical
11.2.11. Indivior
11.2.12. Mundipharma
11.2.13. Zydus Lifesciences
11.2.14. Sanofi
11.2.15. Sandoz
11.2.16. Amneal Pharmaceuticals
11.2.17. Bausch Health
11.2.18. Cipla
11.2.19. Dr. Reddy's Laboratories
11.2.20. Eli Lilly
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Purdue Pharma
  • Mallinckrodt
  • Teva Pharmaceutical Industries
  • Johnson & Johnson
  • Pfizer
  • Sun Pharmaceutical
  • Viatris
  • Hikma Pharmaceuticals
  • Endo International
  • Collegium Pharmaceutical
  • Indivior
  • Mundipharma
  • Zydus Lifesciences
  • Sanofi
  • Sandoz
  • Amneal Pharmaceuticals
  • Bausch Health
  • Cipla
  • Dr. Reddy's Laboratories
  • Eli Lilly

Table Information

Report AttributeDetails
No. of Pages160
PublishedOctober 2026
Forecast Period2026 - 2034
Estimated Market Value ( USD ) in 2026 $ 26.5 Billion
Forecasted Market Value ( USD ) by 2034 $ 38 Billion
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Opioids Market Report 2026 - Product Image

Opioids Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Non-Opioid Pain Treatment Market Report 2026 - Product Image

Non-Opioid Pain Treatment Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Non-opioid Pain Patch Market Outlook 2026-2034: by Patch Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Other Patch Types), Indication (Pain Type), Technology, Distribution Channel - Product Image

Non-opioid Pain Patch Market Outlook 2026-2034: by Patch Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Other Patch Types), Indication (Pain Type), Technology, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
Opioid Use Disorder Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035) - Product Image

Opioid Use Disorder Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

  • Report
  • 350 Pages
  • Global
From
Global Opioids - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Global Opioids - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 125 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.